According to the GuruFocus All-in-One Screener, a Premium feature, the stocks of the following guru-owned health care companies have outperformed the S&P 500 Index over the past 12 months through July 10.
UnitedHealth
UnitedHealth Group Inc. (UNH) has a market cap of $287.94 billion. It has outperformed the S&P 500 by 7.42% over the past year.
Shares are trading with a price-earnings ratio of 7.08. As of Friday, the share price was 61.74% above the 52-week low and 3.87% below the 52-week high.
The company has a GuruFocus profitability rating of 8 out of 10. The return on assets of 29.56% and return on equity of 9.54% are outperforming 68% of companies in the healthcare plans industry. Its financial strength is rated 6 out of 10.
The company’s largest guru shareholder is Vanguard Health Care Fund (Trades, Portfolio) with 0.96% of outstanding shares, followed by Dodge & Cox with 0.89%, Steve Mandel (Trades, Portfolio)’s Lone Pine Capital with 0.49% and Barrow, Hanley, Mewhinney & Strauss with 0.24%.
AbbVie
With a market cap of $169.08 billion, AbbVie Inc. (ABBV) has outperformed the S&P 500 by 38.06% over the past 12 months.
Shares are trading with a price-earnings ratio of 20.41. As of Friday, the price was 53.38% above the 52-week low and 5.27% below the 52-week high.
The U.S. pharmaceutical company has a GuruFocus profitability rating of 9 out of 10. The return on assets of 11.93% is outperforming 88% of companies in the drug manufacturers industry. Its financial strength is rated 4 out of 10. The equity-asset ratio of 0.61 is above the industry median of 0.87.
The company’s largest guru shareholder is Jim Simons (Trades, Portfolio)’ Renaissance Technologies with 0.77% of outstanding shares, followed by Pioneer Investments (Trades, Portfolio) with 0.27% and T Rowe Price Equity Income Fund (Trades, Portfolio) with 0.17%.
Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (TMO) has a market cap of $165.79 billion. It has outperformed the S&P 500 by 36.99% over the past year.
Shares are trading with a price-earnings ratio of 45.36. As of Friday, the price was 67.50% above the 52-week low and 1.09% below the 52-week high.
The company, which sells scientific instruments and laboratory equipment, has a profitability rating of 9 out of 10. The return on equity of 12.68% and return on assets of 6.32% are outperforming 78% of companies in the medical diagnostics and research industry. Its financial strength is rated 5 out of 10. The cash-debt ratio of 0.27 is below the industry median of 1.43.
The company’s largest guru shareholder is PRIMECAP Management (Trades, Portfolio) with 1.23% of outstanding shares, followed by Vanguard Health Care Fund (Trades, Portfolio) with 0.85% and Al Gore (Trades, Portfolio) with 0.48%.
Novo Nordisk
With a market cap of $152.47 billion, Novo Nordisk A/S (NVO) has outperformed the S&P 500 by 21% over the past 12 months.
Shares are trading with a price-earnings ratio of 24.29. As of Friday, the price was 40.78% above the 52-week low and 5.13% below the 52-week high.
The company, which provides diabetes care products, has a GuruFocus profitability rating of 9 out of 10. The return on equity of 76.13% and return on assets of 33.4% are outperforming 98% of companies in the biotechnology industry. Its financial strength is rated 8 out of 10 with a cash-debt ratio of 2.38.
Renaissance Technologies is the company's largest guru shareholder with 1.19% of outstanding shares, followed by Ken Fisher (Trades, Portfolio) with 0.65% and Tom Gayner (Trades, Portfolio) with 0.05%.
Danaher
Danaher Corp. (DHR) has a market cap of $146.73 billion. It has outperformed the S&P 500 by 33.30% over the past 12 months.
Shares are trading with a price-book ratio of 44.29. As of Friday, the price was 72.93% above the 52-week low and 0.10% below the 52-week high.
The company has a profitability rating of 7 out of 10. The return on equity of 10.6% and return on assets of 5.46% are outperforming 75% of companies in the medical diagnostics and research industry. Its financial strength is rated 4 out of 10. The cash-debt ratio of 0.25 is below the industry median of 1.43.
The company’s largest guru shareholder is Vanguard Health Care Fund (Trades, Portfolio) with 0.80% of outstanding shares, followed by Daniel Loeb (Trades, Portfolio) with 0.50%.
Disclosure: I do not own any of the stocks mentioned.
Read more here:
- Insiders Roundup: Bank of America, Rekor Systems
- Kahn Brothers Cuts Merck & Co., Hologic
- Hillman Capital Exits Raytheon, Cuts Amazon
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
